相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The role of HLA B*13:01 and HLA B*15:02 for predicting sulfonamide/trimethoprim-induced Severe Cutaneous Adverse Reactions (SCARs)
Kanokkarn Pinyopornpanish et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2023)
The IPD-IMGT/HLA Database
Dominic J. Barker et al.
NUCLEIC ACIDS RESEARCH (2023)
Integrating real-world data in cost-effectiveness analysis of universal HLA-B15:02 screening in Malaysia
Huey Yi Chong et al.
BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)
Validation and application of new NGS-based HLA genotyping to clinical diagnostic practice
Ji Yeon Kim et al.
HLA (2023)
The pharmacogenomics of carbamazepine-induced cutaneous adverse drug reaction in the South of Vietnam
Ai-Hoc Nguyen et al.
FRONTIERS IN PHARMACOLOGY (2023)
Repurposing HLA genotype data of renal transplant patients to prevent severe drug hypersensitivity reactions
Lisanne E. N. Manson et al.
FRONTIERS IN GENETICS (2023)
Identification of the novel HLA-A*68:100 allele by PCR-SBT in a Chinese bone marrow donor
Yuanyuan Liu et al.
HLA (2021)
Cost-effectiveness analysis of genotyping for HLA-B*15:02 in Indonesian patients with epilepsy using a generic model
Rika Yuliwulandari et al.
PHARMACOGENOMICS JOURNAL (2021)
Association between the HLA-B*1502 gene and mild maculopapular exanthema induced by antiepileptic drugs in Northwest China
Nilupaer Shafeng et al.
BMC NEUROLOGY (2021)
IPD-IMGT/HLA Database
James Robinson et al.
NUCLEIC ACIDS RESEARCH (2020)
High-Throughput Two-Dimensional Polymerase Chain Reaction Technology
Yuxia Zhan et al.
ANALYTICAL CHEMISTRY (2020)
Association of carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis with the HLA-B75 serotype or HLA-B*15:21 allele in Filipino patients
Francis Capule et al.
PHARMACOGENOMICS JOURNAL (2020)
Toxic Epidermal Necrolysis and Steven-Johnson Syndrome: A Comprehensive Review
Olivia A. Charlton et al.
ADVANCES IN WOUND CARE (2020)
Usage Pattern of Carbamazepine and Associated Severe Cutaneous Adverse Reactions in Singapore Following Implementation of HLA-B*15:02 Genotyping as Standard-of-Care
Cynthia Sung et al.
FRONTIERS IN PHARMACOLOGY (2020)
A Screening Test for HLA-B*15:02 in a Large United States Patient Cohort Identifies Broader Risk of Carbamazepine-Induced Adverse Events
Hua Fang et al.
FRONTIERS IN PHARMACOLOGY (2019)
HLA-B*57:01 confers genetic susceptibility to carbamazepine-induced SJS/TEN in Europeans
Maja Mockenhaupt et al.
ALLERGY (2019)
HLA testing in the molecular diagnostic laboratory
Kathleen Madden et al.
VIRCHOWS ARCHIV (2019)
SNP-based HLA allele tagging, imputation and association with antiepileptic drug-induced cutaneous reactions in Hong Kong Han Chinese
H. Gui et al.
PHARMACOGENOMICS JOURNAL (2018)
Association between HLA-B Alleles and Carbamazepine-Induced Maculopapular Exanthema and Severe Cutaneous Reactions in Thai Patients
Chonlaphat Sukasem et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2018)
Risk and association of HLA with oxcarbazepine-induced cutaneous adverse reactions in Asians
Chun-Bing Chen et al.
NEUROLOGY (2017)
Association of HLA-B*15:13 and HLA-B*15:02 with phenytoin-induced severe cutaneous adverse reactions in a Malay population
C-C Chang et al.
PHARMACOGENOMICS JOURNAL (2017)
Association of the HLA-B alleles with carbamazepine-induced Stevens- Johnson syndrome/toxic epidermal necrolysis in the Javanese and Sundanese population of Indonesia: the important role of the HLA-B75 serotype
Rika Yuliwulandari et al.
PHARMACOGENOMICS (2017)
Significant HLA class I type associations with aromatic antiepileptic drug (AED)-induced SJS/TEN are different from those found for the same AED-induced DRESS in the Spanish population
Elena Ramirez et al.
PHARMACOLOGICAL RESEARCH (2017)
A study of HLA-B*15:02 in 9 different Chinese ethnics: Implications for carbamazepine related SJS/TEN
G. J. Ou et al.
HLA (2017)
A novel multiplex polymerase chain reaction assay for detection of both HLA-A*31:01/HLA-B*15:02 alleles, which confer susceptibility to carbamazepine-induced severe cutaneous adverse reactions
D. V. Nguyen et al.
HLA (2017)
A study of HLA-B*15:02 in a Sri Lankan population: Implications for pharmacogenomic testing
K. M. D. Gunathilake et al.
HUMAN IMMUNOLOGY (2016)
HLA-A, HLA-B and HLA-DRB1 allele and haplotype frequencies of 10918 Koreans from bone marrow donor registry in Korea
H. Park et al.
INTERNATIONAL JOURNAL OF IMMUNOGENETICS (2016)
Pharmacogenetics of abacavir hypersensitivity: A systematic review and meta-analysis of the association with HLA-B*57:01
Bernardo Sousa-Pinto et al.
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY (2015)
HLA-B*15:02 association with carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in an Indian population: a pooled-data analysis and meta-analysis
Amy Hui-Ping Khor et al.
EPILEPSIA (2014)
HLA-B*1502 is associated with carbamazepine induced Stevens-Johnson syndrome in North Indian population
Ritu Aggarwal et al.
HUMAN IMMUNOLOGY (2014)
Building pharmacogenetics into a pharmacovigilance program in Singapore: using serious skin rash as a pilot study
D. S. L. Toh et al.
PHARMACOGENOMICS JOURNAL (2014)
HLA-B*58:01 is a risk factor for allopurinol-induced DRESS and Stevens-Johnson syndrome/toxic epidermal necrolysis in a Portuguese population
M. Goncalo et al.
BRITISH JOURNAL OF DERMATOLOGY (2013)
Association between the HLA-B*15:02 allele and carbamazepine-induced Stevens-Johnson syndrome/toxic epidermal necrolysis in Han individuals of northeastern China
Xiao-Jing He et al.
PHARMACOLOGICAL REPORTS (2013)
Association between HLA-B☆58:01 allele and severe cutaneous adverse reactions with allopurinol in Han Chinese in Hong Kong
M. L. S. Chiu et al.
BRITISH JOURNAL OF DERMATOLOGY (2012)
HLA-B*1502 Strongly Predicts Carbamazepine-Induced Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Thai Patients with Neuropathic Pain
Kongkiat Kulkantrakorn et al.
PAIN PRACTICE (2012)
Strong association between HLA-B*1502 and carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in mainland Han Chinese patients
Yan Zhang et al.
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY (2011)
Genome-wide association study identifies HLA-A*3101 allele as a genetic risk factor for carbamazepine-induced cutaneous adverse drug reactions in Japanese population
Takeshi Ozeki et al.
HUMAN MOLECULAR GENETICS (2011)
Association of HLA-B*1502 allele with carbamazepine-induced toxic epidermal necrolysis and Stevens-Johnson syndrome in the multi-ethnic Malaysian population
Choong-Chor Chang et al.
INTERNATIONAL JOURNAL OF DERMATOLOGY (2011)
HLA-A*3101 and Carbamazepine-Induced Hypersensitivity Reactions in Europeans
Mark McCormack et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations
Faviel F. Gonzalez-Galarza et al.
NUCLEIC ACIDS RESEARCH (2011)
HLA-B*1511 is a risk factor for carbamazepine-induced Stevens-Johnson syndrome and toxic epidermal necrolysis in Japanese patients
Nahoko Kaniwa et al.
EPILEPSIA (2010)
Association between HLA-B*1502 and carbamazepine-induced severe cutaneous adverse drug reactions in a Thai population
Wichittra Tassaneeyakul et al.
EPILEPSIA (2010)
HLA Class I markers in Japanese patients with carbamazepine-induced cutaneous adverse reactions
Hiroko Ikeda et al.
EPILEPSIA (2010)
Association of HLA-B*1502 allele and carbamazepine-induced Stevens-Johnson syndrome among Indians
Timir Y. Mehta et al.
INDIAN JOURNAL OF DERMATOLOGY VENEREOLOGY & LEPROLOGY (2009)
Carbamazepine, HLA-B*1502 and risk of Stevens-Johnson syndrome and toxic epidermal necrolysis: US FDA recommendations
P. Brent Ferrell et al.
PHARMACOGENOMICS (2008)
HLA class I (A, B, C) and class II (DRB1, DQA1, DQB1, DPB1) alleles and haplotypes in the Han from southern China
E. Trachtenberg et al.
TISSUE ANTIGENS (2007)
Distributions of HLA class i alleles and haplotypes in Northern Han Chinese
W Hong et al.
TISSUE ANTIGENS (2005)
分享论文
